Sinha Vikas
- SEC CIK
- 0001337845
In the past year, 2 open-market sale filings worth $1.23M and no purchases.
Current role at each company
- SRRK Scholar Rock Holding CorpChief Financial Officeras of Apr 20, 2026
- VRNA Verona Pharma plcDirectoras of Oct 8, 2025
- KLRS Kalaris Therapeutics, Inc.See Remarksas of Feb 24, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.23M
- 2 filings
- Net
- −$1.23M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sinha Vikas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRRK Scholar Rock Holding Corp
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 (view filing) | Jan 13 | 2 days | Sinha VikasChief Financial Officer | SSale | −16.8K | $42.70 | −$715.4K | −2.8%583.2K after | |
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Sinha VikasChief Financial Officer | SSale | −10.4K | $49.57 | −$516.0K | −1.7%619.9K after |
VRNA Verona Pharma plc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2025 (view filing) | Apr 29 | 23 days | Sinha VikasDirector | SSale | −160.0K | $8.92 | −$1.43M | −68.2%74.4K after | Amended2 lots10b5-1 |
| May 22, 2025 (view filing) | May 20 | 2 days | Sinha VikasDirector | SSale | −160.0K | $9.39 | −$1.50M | −68.2%74.4K after | 10b5-1 |
| Aug 5, 2025 (view filing) | Aug 1 | 4 days | Sinha VikasDirector | SSale | −4.33K | $13.14 | −$56.9K | −4.4%94.1K after |
KLRS Kalaris Therapeutics, Inc.
See Remarks31 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2022 (view filing) | Jan 20 | 4 days | Sinha VikasSee Remarks | SSale | −6.45K | $8.75 | −$56.4K | −0.7%859.0K after | |
| Apr 22, 2022 (view filing) | Apr 20 | 2 days | Sinha VikasSee Remarks | SSale | −1.16K | $6.68 | −$7.76K | −0.1%906.6K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Sinha VikasSee Remarks | SSale | −1.43K | $5.21 | −$7.46K | −0.2%938.2K after | |
| Oct 26, 2022 (view filing) | Oct 20 | 6 days | Sinha VikasSee Remarks | SSale | −1.45K | $9.36 | −$13.6K | −0.1%1.04M after | Amended |
| Jan 23, 2023 (view filing) | Jan 19-20 | 4 days | Sinha VikasSee Remarks | SSale | −6.54K | $5.09 | −$33.3K | −0.6%1.03M after | 2 lots |
| Apr 21, 2023 (view filing) | Apr 19-20 | 2 days | Sinha VikasSee Remarks | SSale | −2.68K | $3.67 | −$9.84K | −0.2%1.19M after | 2 lots10b5-1 |
| Jul 6, 2023 (view filing) | Jul 5 | 1 day | Sinha VikasSee Remarks | SSale | −2.98K | $3.05 | −$9.10K | −0.3%1.19M after | 10b5-1 |
| Jul 21, 2023 (view filing) | Jul 19-20 | 2 days | Sinha VikasSee Remarks | SSale | −2.63K | $3.45 | −$9.08K | −0.2%1.18M after | 2 lots10b5-1 |
| Aug 21, 2023 (view filing) | Aug 17 | 4 days | Sinha VikasSee Remarks | SSale | −10.5K | $2.50 | −$26.3K | −0.9%1.17M after | 10b5-1 |
| Oct 5, 2023 (view filing) | Oct 3 | 2 days | Sinha VikasSee Remarks | SSale | −755 | $1.98 | −$1.49K | −0.1%1.17M after | 10b5-1 |